BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37747645)

  • 1. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images.
    Young T; Lee M; Johnston M; Nguyen T; Ko R; Arumugam S
    Phys Eng Sci Med; 2023 Dec; 46(4):1619-1627. PubMed ID: 37747645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer.
    El-Bared N; Portelance L; Spieler BO; Kwon D; Padgett KR; Brown KM; Mellon EA
    Pract Radiat Oncol; 2019 Jan; 9(1):e46-e54. PubMed ID: 30149192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk.
    Loi M; Magallon-Baro A; Suker M; van Eijck C; Sharma A; Hoogeman M; Nuyttens J
    Radiother Oncol; 2019 May; 134():67-73. PubMed ID: 31005226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.
    Karava K; Ehrbar S; Riesterer O; Roesch J; Glatz S; Klöck S; Guckenberger M; Tanadini-Lang S
    Radiat Oncol; 2017 Nov; 12(1):175. PubMed ID: 29121945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR).
    Kim M; Schiff JP; Price A; Laugeman E; Samson PP; Kim H; Badiyan SN; Henke LE
    Radiat Oncol; 2022 Sep; 17(1):157. PubMed ID: 36100866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective evaluation of decision-making for pancreatic stereotactic MR-guided adaptive radiotherapy.
    Tyran M; Jiang N; Cao M; Raldow A; Lamb JM; Low D; Luterstein E; Steinberg ML; Lee P
    Radiother Oncol; 2018 Nov; 129(2):319-325. PubMed ID: 30174107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
    Li G; Cohen P; Xie H; Low D; Li D; Rimner A
    Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dosimetric effect of electron density overrides in 3DCRT Lung SBRT for a range of lung tumor dimensions.
    Healy GEA; Marsh SH; Cousins AT
    J Appl Clin Med Phys; 2018 Nov; 19(6):79-87. PubMed ID: 30199127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of HDR brachytherapy-replicating prostate radiotherapy planning for tomotherapy, cyberknife and VMAT.
    de Chavez R; Grogan G; Hug B; Howe K; Grigg A; Waterhouse D; Lane J; Glyde A; Brown E; Bydder S; Pryor D; Hargrave C; Charles PH; Hellyer J; Ebert MA
    Med Dosim; 2022 Spring; 47(1):61-69. PubMed ID: 34551879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.
    Henke L; Kashani R; Yang D; Zhao T; Green O; Olsen L; Rodriguez V; Wooten HO; Li HH; Hu Y; Bradley J; Robinson C; Parikh P; Michalski J; Mutic S; Olsen JR
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1078-1086. PubMed ID: 27742541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Various Dose Normalization Strategies When Implementing Linear Boltzmann Transport Equation Dose Calculation for Lung Stereotactic Body Radiation Therapy Planning.
    Erickson BG; Ackerson BG; Kelsey CR; Yin FF; Adamson J; Cui Y
    Pract Radiat Oncol; 2022; 12(5):446-456. PubMed ID: 35219882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.
    Wilke L; Moustakis C; Blanck O; Albers D; Albrecht C; Avcu Y; Boucenna R; Buchauer K; Etzelstorfer T; Henkenberens C; Jeller D; Jurianz K; Kornhuber C; Kretschmer M; Lotze S; Meier K; Pemler P; Riegler A; Röser A; Schmidhalter D; Spruijt KH; Surber G; Vallet V; Wiehle R; Willner J; Winkler P; Wittig A; Guckenberger M; Tanadini-Lang S
    Strahlenther Onkol; 2021 Sep; 197(9):836-846. PubMed ID: 34196725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
    Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.